Stella02.png
STELLA:
Strengthening Translational Ecosystems for Lifesaving Local Access

#innovation #globalhealth #healthcare

Born from an idea where innovation meets public health, and guided by the fundamental principle that everyone deserves access to equitable, functioning health systems, the STELLA Center of Excellence was created as a vehicle to consolidate the expertise, creativity, knowledge, and passion of stakeholders across global healthcare. STELLA is designed to create a global ecosystem of partners for the conception and implementation of innovative healthcare solutions in low- and middle- income countries (LMIC). Together with us, STELLA was co-founded by Novartis and the Swiss TPH. Its mission is bold and its scope broad enough to encompass wide-reaching development goals, but contained enough to drive effective change.

STELLA aims to continue addressing health system challenges throughout the world by growing its network and opening its platform for the development of systems-driven solutions. Our partners include academic institutions, pharmaceutical companies, multilateral health organizations, health tech innovators, governments, and philanthropic organizations, among others.

STELLA ultimately intends to drive systems-level changes that are forward-thinking and sustainable to build better health systems for all. 

Under the STELLA umbrella, we are currently running focused projects to address health systems challenges:

 

1

 

Logistics Management Information System for better access to medicine
 

Supply chain inefficiencies are the primary cause for poor drug availability, especially in hard-to-reach areas of LMICs. A transparent, data-driven logistics management information system (LMIS) is the cornerstone for the development of a functioning supply chain in LMICs, particularly sub-Saharan Africa. 

DHIS2 is an open-source health management information systems platform used in low- and middle-income countries (LMIC) to collect and organize health data, and is considered the global gold standard for HMIS in LMICs. Together with the University of Oslo and Novartis, we are currently developing an open-source, continent-compatible predictive LMIS integrated within the DHIS2 network which couples real-time supply information at the point of care with case and epidemiological data. This will be the first open-source system with the potential to fully enable robust access to medicines when they are needed, where they are needed. 

 

2

 

Infectious Disease Tracker

Supply chain inefficiencies are the primary cause for poor drug availability, especially in hard-to-reach areas of LMICs. A transparent, data-driven logistics management information system (LMIS) is the cornerstone for the development of a functioning supply chain in LMICs, particularly sub-Saharan Africa. 

DHIS2 is an open-source health management information systems platform used in low- and middle-income countries (LMIC) to collect and organize health data, and is considered the global gold standard for HMIS in LMICs. Together with the University of Oslo and Novartis, we are currently developing an open-source, continent-compatible predictive LMIS integrated within the DHIS2 network which couples real-time supply information at the point of care with case and epidemiological data. This will be the first open-source system with the potential to fully enable robust access to medicines when they are needed, where they are needed. 

 

3

 

Making African Health Innovation Works

Start-ups and entrepreneurs are crucial instruments to bring innovations to the people. This holds true across sectors and geographies, but especially so in resource-poor settings. In collaboration with the Swiss Government (State Secretariat for Education, Research and Innovation),  STELLA introduces a new start-up program, focusing on making innovation work. 

The program goes beyond the usual start-up competitions or pitching events. Through challenges, which are identified by the broader STELLA network, African startups will be supported to prototype and validate their solutions, in collaboration with local delivery partners (i.e. health innovation centres in Africa), and local, Swiss and even global validation partners (academia, research centres, public health experts). 

Challenges will for example be:

  • Addressing the Non-communicable disease “pandemic” through prevention and smart patient management

  • Making medicine available and accessible for the people in need. In the right place. At the right time. 
     

Through the “Making African Health Innovation Work” programme, STELLA strengthens entrepreneurial solutions, true to its core mission, and enlarges global health translational ecosystems!

 

SHAPE BOTTOM sTELLA.png
The TEAM

Click on one of us to open their LinkedIn

Hexagon Femmina-stella.png

Alessandro Mazzetti

Innovation Office

Hexagon Femmina-stella.png

Aliya Karim

Innovation Office

Hexagon Femmina-stella.png

Christian Elias Schneider Innovation Office

Hexagon Femmina-stella2.png

Georg Hofstetter

Novartis

Hexagon Femmina-stella2.png

Hans-Peter Beck Swiss TPH

Hexagon Femmina-stella2.png

Pascal Fröhlicher

Entrepreneur

Stella2 news.png
Stella News
Risorsa 168.png